Description:
For the treatment of tick and flea infestations on dogs for 3 months. This veterinary medicinal product is a systemic insecticide and acaricide with a long duration of action that provides immediate and persistent tick and flea killing activity for 3 months.
Composition:
Each chewable tablet contains:
| Bravecto® chewable tablets | Fluralaner (mg) |
| For Very small dogs (2 – 4.5 kg) | 112.5 |
| For small dogs (> 4.5 – 10 kg) | 250 |
| For medium-sized dogs (>10 – 20 kg) | 500 |
| For large dogs (> 20 – 40 kg) | 1000 |
| For very large dogs (> 40 – 56 kg) | 1400 |
Indications for use:
For the treatment of tick and flea infestations on dogs for 3 months.
Provides immediate and persistent tick (adult and juvenile Ixodes ricinus, Ixodes hexagonus, Ixodes scapularis, Ixodes holocyclus, Dermacentor reticulatus, Dermacentor variabilis and Rhipicephalus sanguineus) and flea (Ctenocephalides felis and Ctenocephalides canis) killing activity for 3 months.
For the treatment of Demodicosis caused by Demodex spp. mites.
For the treatment of Sarcoptic mange and Otodectes spp. mite infestations in dogs.
Provides protection against transmission of Babesia canis by Dermacentor reticulatus ticks by killing the ticks before disease transmission occurs.
Precautions:
Bravecto® chewable tablets should not be used in puppies less than 8 weeks of age or weighing less than 2kg.
Contraindications:
Do not use in case of hypersensitivity to the active substance or to any of the excipients.
Storage:
Do not store above 30°C.
Presentation:
Fluralanar 112.5 mg/ 500 mg/ 1000 mg/ 1400 mg
